Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRORP, or Protein only RNase P catalytic subunit (also known as MRPP3), is a mitochondrial enzyme that functions as the catalytic core of the mitochondrial RNase P complex. Its primary biological function is to catalyze the precise 5'-end processing of mitochondrial precursor tRNAs (pre-tRNAs), an essential step for the maturation of tRNAs and subsequent mitochondrial protein synthesis. Unlike its bacterial and nuclear counterparts, mitochondrial RNase P in humans is a protein-only complex. Mutations in the gene encoding PRORP are linked to severe mitochondrial disorders, such as combined oxidative phosphorylation deficiency (COXPD), particularly COXPD54, characterized by neurological deficits, hypotonia, and lactic acidosis, highlighting its critical role in mitochondrial gene expression and overall mitochondrial health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein only RNase P catalytic subunit (PRORP).